Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
08/08/2023* 16:30 EST Earnings Call Q2 2023 -- -- --
03/01/2023* -- Results Q4 2022 -- -0.12 --
11/09/2022 16:30 EST Earnings Call Q3 2022 -- -- --
11/09/2022 -- Results Q3 2022 -0.04 -0.09 55.56%
08/08/2022 16:30 EST Earnings Call Q2 2022 -- -- --
08/08/2022 -- Results Q2 2022 -0.08 -0.14 39.43%
05/09/2022 -- Results Q1 2022 -0.09 -0.13 27.67%
03/01/2022 -- Results Q4 2021 -0.13 -0.18 27.78%
*Estimated Date/Time

Earnings

Next Report Date 03/01/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/09/2022
Beat/Miss Upgrade
Return Since 24.49%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals; Exemplar, and Trans Ova. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
URL http://www.precigen.com
Investor Relations URL https://investors.precigen.com/
HQ State/Province Maryland
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Mar. 01, 2023 (est.)
Last Earnings Release Nov. 09, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
-19.40%
-52.13%
-43.23%
-16.21%
86.13%
-63.63%
-59.03%
20.39%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
7.86%
-12.35%
8.13%
-86.93%
-32.01%
66.51%
-37.19%
-75.44%
46.43%
--
-23.26%
-66.73%
-14.05%
-6.73%
-85.10%
-97.98%
-15.81%
--
--
--
--
-85.40%
-78.30%
-98.96%
6.92%
--
--
--
--
--
--
-83.19%
34.57%
As of February 03, 2023.

Profile

Edit
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals; Exemplar, and Trans Ova. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
URL http://www.precigen.com
Investor Relations URL https://investors.precigen.com/
HQ State/Province Maryland
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Mar. 01, 2023 (est.)
Last Earnings Release Nov. 09, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

No data available
Symbol Dollars Invested % Weight
     
     
     
     
     
     
     
     
     
     

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter PGEN Tweets